Photodynamic therapy of actinic keratosis at varying fluence rates:: assessment of photobleaching, pain and primary clinical outcome

被引:124
作者
Ericson, MB [1 ]
Sandberg, C
Stenquist, B
Gudmundson, F
Karlsson, M
Ros, AM
Rosén, A
Larkö, O
Wennberg, AM
Rosdahl, I
机构
[1] Gothenburg Univ, Chalmers Univ Technol, Sch Phys & Engn Phys, Dept Expt Phys, SE-41296 Gothenburg, Sweden
[2] Gothenburg Univ, Sahlgrens Univ Hosp, Dept Dermatol, SE-41345 Gothenburg, Sweden
[3] Karolinska Hosp, Dept Dermatol, SE-17177 Stockholm, Sweden
[4] Linkoping Univ Hosp, Fac Hlth Sci, Div Dermatol, Dept Biomed & Surg, SE-58183 Linkoping, Sweden
关键词
actinic keratosis; fluence rate; fluorescence imaging; pain; photobleaching; photodynamic therapy;
D O I
10.1111/j.1365-2133.2004.06211.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Although photodynamic therapy (PDT) is becoming an important treatment method for skin lesions such as actinic keratosis (AK) and superficial basal cell carcinoma, there are still discussions about which fluence rate and light dose are preferable. Recent studies in rodents have shown that a low fluence rate is preferable due to depletion of oxygen at high fluence rates. However, these results have not yet been verified in humans. Objective The objective was to investigate the impact of fluence rate and spectral range on primary treatment outcome and bleaching rate in AK using aminolaevulinic acid PDT. In addition, the pain experienced by the patients has been monitored during treatment. Patients/methods Thirty-seven patients (mean age 71 years) with AK located on the head, neck and upper chest were treated with PDT, randomly allocated to four groups: two groups with narrow filter (580-650 nm) and fluence rates of 30 or 45 mW cm(-2), and two groups with broad filter (580-690 nm) and fluence rates of 50 or 75 mW cm(-2). The total cumulative light dose was 100 J cm(-2) in all treatments. Photobleaching was monitored by fluorescence imaging, and pain experienced by the patients was registered by using a visual analogue scale graded from 0 (no pain) to 10 (unbearable pain). The primary treatment outcome was evaluated at a follow-up visit after 7 weeks. Results Our data showed a significant correlation between fluence rate and initial treatment outcome, where lower fluence rate resulted in favourable treatment response. Moreover, the photobleaching dose (1/e) was found to be related to fluence rate, ranging from 4.5 +/- 1.0 J cm(-2) at 30 mW cm(-2), to 7.3 +/- 0.7 J cm(-2) at 75 mW cm(-2), indicating higher oxygen levels in tissue at lower fluence rates. After a cumulative light dose of 40 J cm(-2) no further photobleaching took place, implying that higher doses are excessive. No significant difference in pain experienced by the patients during PDT was observed in varying the fluence rate from 30 to 75 mW cm(-2). However, the pain was found to be most intense up to a cumulative light dose of 20 J cm(-2). Conclusions Our results imply that the photobleaching rate and primary treatment outcome are dependent on fluence rate, and that a low fluence rate (30 mW cm(-2)) seems preferable when performing PDT of AK using noncoherent light sources.
引用
收藏
页码:1204 / 1212
页数:9
相关论文
共 47 条
[1]  
Bagdonas S, 2000, PHOTOCHEM PHOTOBIOL, V72, P186, DOI 10.1562/0031-8655(2000)072<0186:POAAIP>2.0.CO
[2]  
2
[3]   MECHANISMS FOR THE PHOTO-OXIDATION OF PROTOPORPHYRIN-IX IN SOLUTION [J].
COX, GS ;
WHITTEN, DG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1982, 104 (02) :516-521
[4]   A spectroscopic study of the photobleaching of protoporphyrin IX in solution [J].
Ericson, MB ;
Grapengiesser, S ;
Gudmundson, F ;
Wennberg, AM ;
Larkö, O ;
Moan, J ;
Rosén, A .
LASERS IN MEDICAL SCIENCE, 2003, 18 (01) :56-62
[5]   Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light [J].
Fink-Puches, R ;
Hofer, A ;
Smolle, J ;
Kerl, H ;
Wolf, P .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1997, 41 (1-2) :145-151
[6]  
Finlay JC, 2001, PHOTOCHEM PHOTOBIOL, V73, P54, DOI 10.1562/0031-8655(2001)073<0054:PBAPIS>2.0.CO
[7]  
2
[9]   OXYGEN-CONSUMPTION AND DIFFUSION EFFECTS IN PHOTODYNAMIC THERAPY [J].
FOSTER, TH ;
MURANT, RS ;
BRYANT, RG ;
KNOX, RS ;
GIBSON, SL ;
HILF, R .
RADIATION RESEARCH, 1991, 126 (03) :296-303
[10]  
FOSTER TH, 1993, CANCER RES, V53, P1249